Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from GLP-1 receptor agonists to GLP-1/GIP co-agonists and eating behavior in type 2 diabetes
jRCT1041230070Recruiting
- Start
- Aug 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by none. Primary endpoint: Change in HbA1c at 12 weeks. Started Aug 2023; status: recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1041230070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230070.